Document:

Exhibit
4.4

 

FORM
OF UNDERWRITERS’ WARRANT AGREEMENT

 

THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE
WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN,
PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED
BELOW) TO ANYONE OTHER THAN (I) THE BENCHMARK COMPANY LLC OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING,
OR (II) A BONA FIDE OFFICER OR PARTNER OF THE BENCHMARK COMPANY LLC OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.

 

THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [●], 20[●]. VOID AFTER 5:00 P.M., EASTERN TIME, [●], 20[●]1.

 

WARRANT
TO PURCHASE CLASS B ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES

[●]
American Depositary Shares for the Purchase of [●] Ordinary Shares

of

WIMI
HOLOGRAM CLOUD, INC.

 

1.
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of The Benchmark Company
LLC (“Holder”), as registered owner of this Purchase Warrant, to WiMi Hologram Cloud, Inc., a corporation governed
by the laws of the Cayman Islands (the “Company”), Holder is entitled, at any time or from time to time from
[●], 20[●] (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●], 20[●],
which will be the five-year anniversary of the effective date of the Company’s Form F-1 registration statement (File No.333-[●])
(such date, the “Effective Date”) (the “Expiration Date”), but not thereafter, to subscribe
for, purchase and receive, in whole or in part, up to [●] Class B ordinary shares of the Company, par value $0.0001 (the
“Shares”), subject to adjustment as provided in Section 6 hereof, represented by [●] American Depositary
Shares (the “ADSs”), each [●] Shares representing one (1) ADS, subject to adjustment hereunder (the “Warrant
ADSs”). If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase
Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period
ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase
Warrant is initially exercisable at $[●]2 per Warrant ADS; provided, however, that upon the occurrence
of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise
price per Warrant ADS and the number of ADSs to be received upon such exercise, shall be adjusted as therein specified. The term
“Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

 

2.
Exercise.

 

2.1.
Exercise Form. In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and
completed and delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Warrant
ADSs being purchased payable in cash by wire transfer of immediately available funds to an account designated by the Company or
by certified check or official bank check. If the subscription rights represented hereby shall not be exercised at or before 5:00
p.m., Eastern time, on the Expiration Date, this Purchase Warrant shall become and be void without further force or effect, and
all rights represented hereby shall cease and expire.

 

 

		1	Date that is 5 years from the Effective Date.

		2	100% of the price of the [ADSs] sold in the initial public
offering.

 

    -1-

     

    

 

2.2.
Cashless Exercise. In lieu of exercising this Purchase Warrant by payment of cash or check payable to the order of the
Company pursuant to Section 2.1 above, Holder may elect to receive the number of ADSs equal to the value of this Purchase
Warrant (or the portion thereof being exercised), by surrender of this Purchase Warrant to the Company, together with the exercise
form attached hereto, in which event the Company will issue to Holder ADSs in accordance with the following formula:

 

	X	=	 	Y(A-B)
    	 	 
	 	A
    	 	 	 
	Where,	 	 	 	 	 	 	 
	 	 	X	 	=	 	The
    number of Warrant ADS to be issued to Holder;	 
	 	 	Y	 	=	 	The
    number of Warrant ADS for which the Purchase Warrant is being exercised;	 
	 	 	A	 	=	 	The
    fair market value of one ADS; and	 
	 	 	B	 	=	 	The
    Exercise Price.	 
	 	 	 	 	 	 	 	 

For
purposes of this Section 2.2, the fair market value of a Share is defined as follows:

 

	 	(i)	if
    the Company’s ADSs are traded on a securities exchange, the value shall be deemed to be the closing price on such exchange
    prior to the exercise form being submitted in connection with the exercise of the Purchase Warrant; 
	 	 	 
	 	(ii)
	if
the Company’s ADSs are actively traded over-the-counter, the value shall be deemed to be the closing bid prior to the exercise
form being submitted in connection with the exercise of the Purchase Warrant; or

	 	 	 
	 	(iii)	if
        there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the
        Company’s Board of Directors.

 

2.3.
Legend. Unless otherwise registered under the Securities Act of 1933, as amended (the “Act”), Each certificate
for the securities purchased under this Purchase Warrant shall bear a legend as follows unless such securities have been registered
under the Act:

 

“The
securities represented by this certificate have not been registered under the Securities Act of 1933, as amended (the “Act”),
or applicable state law. Neither the securities nor any interest therein may be offered for sale, sold or otherwise transferred
except pursuant to an effective registration statement under the Act, or pursuant to an exemption from registration under the
Act and applicable state law which, in the opinion of counsel to the Company, is available.”

 

2.4.
Resale of Shares. Holder and the Company acknowledge that as of the date hereof the Staff of the Division of Corporation
Finance of the SEC has published Compliance & Disclosure Interpretation 528.04 in the Securities Act Rules section thereof,
stating that the holder of securities issued in connection with a public offering may not rely upon Rule 144 promulgated under
the Act to establish an exemption from registration requirements under Section 4(a)(1) under the Act, but may nonetheless apply
Rule 144 constructively for the resale of such shares in the following manner: (a) provided that six (6) months has elapsed since
the last sale under the registration statement, an underwriter or finder may resell the securities in accordance with the provisions
of Rule 144(c), (e), and (f), except for the notice requirement; (b) a purchaser of the shares from an underwriter receives restricted
securities unless the sale is made with an appropriate, current prospectus, or unless the sale is made pursuant to the conditions
contained in (a) above; (c) a purchaser of the shares from an underwriter who receives restricted securities may include the underwriter’s
holding period, provided that the underwriter or finder is not an affiliate of the issuer; and (d) if an underwriter transfers
the shares to its employees, the employees may tack the firm’s holding period for purposes of Rule 144(d), but they must aggregate
sales of the distributed shares with those of other employees, as well as those of the underwriter or finder, for a six-month
period from the date of the transfer to the employees. Holder and the Company also acknowledge that the Staff of the Division
of Corporation Finance of the SEC has advised in various no-action letters that the holding period associated with securities
issued without registration to a service provider commences upon the completion of the services, which the Company agrees and
acknowledges shall be the closing of the Offering, and that Rule 144(d)(3)(ii) provides that securities acquired from the issuer
solely in exchange for other securities of the same issuer shall be deemed to have been acquired at the same time as the securities
surrendered for conversion (which the Company agrees is the date of the initial issuance of this Purchase Warrant). In the event
that following a request by Holder to transfer the Warrant ADSs in accordance with Compliance & Disclosure Interpretation
528.04 counsel for the Company reasonably concludes that Compliance & Disclosure Interpretation 528.04 no longer may be relied
upon as a result of changes in applicable laws, regulations, or interpretations of the SEC Division of Corporation Finance, or
as a result of judicial interpretations not known by the Company or its counsel on the date hereof (either, a “Registration
Trigger Event”), then the Company shall promptly, and in any event within five (5) Business Days following the request,
provide written notice to Holder of such determination. As a condition to giving such notice, the Company shall offer Holder a
single demand registration right pursuant to an agreement in form acceptable to the Holder; provided that notwithstanding anything
to the contrary, the obligations of the Company pursuant to this Section 2 shall terminate on the fifth (5th) anniversary
of the Effective Date. In the absence of such conclusion by counsel for the Company, the Company shall, upon request of Holder
given no earlier than six (6) months after the final closing of the Offering, instruct its transfer agent to permit the transfer
of such shares in accordance with Compliance & Disclosure Interpretation 528.04, provided that Holder has provided such documentation
as shall be reasonably be requested by the Company to establish compliance with the conditions of Compliance & Disclosure
Interpretation 528.04.

 

    -2-

     

    

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action
to close.

 

3.
Transfer.

 

3.1.
General Restrictions. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that
such Holder will not: (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty
(180) days following the Effective Date to anyone other than: (i) The Benchmark Company LLC (“Benchmark”) or
an underwriter or a selected dealer participating in the Offering, or (ii) a bona fide officer or partner of Benchmark or of any
such underwriter or selected dealer, in each case in accordance with FINRA Conduct Rule 5110(g)(1), or (b) cause this Purchase
Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction
that would result in the effective economic disposition of this Purchase Warrant or the securities hereunder, except as provided
for in FINRA Rule 5110(g)(2). One hundred eighty (180) days after the Effective Date, transfers to others may be made subject
to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver
to the Company the assignment form attached hereto duly executed and completed, together with the Purchase Warrant and payment
of all transfer taxes, if any, payable in connection therewith. Subject to applicable securities laws, the Company shall within
five (5) Business Days transfer this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase
Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate
number of Warrant ADSs purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.

 

4.
Registration Rights.

 

4.1.
Demand Registration.

 

4.1.1.
Grant of Right. The Company, upon written demand (a “Demand Notice”) of the holder(s) of at least 51%
of the Purchase Warrants and/or the underlying Warrant ADSs (“Majority Holders”), agrees to register, on one
occasion, all or any portion of the Warrant ADSs underlying the Purchase Warrants (collectively, the “Registrable Securities”).
On such occasion, the Company will file a registration statement with the U.S. Securities and Exchange Commission (the “Commission”)
covering the Registrable Securities within sixty (60) days after receipt of a Demand Notice and use its reasonable best efforts
to have the registration statement declared effective promptly thereafter, subject to compliance with review by the Commission;
provided, however, that the Company shall not be required to comply with a Demand Notice if the Company has filed a registration
statement with respect to which the Holder is entitled to piggyback registration rights pursuant to Section 4.2 hereof and either:
(i) the Holder has elected to participate in the offering covered by such registration statement or (ii) if such registration
statement relates to an underwritten primary offering of securities of the Company, until the offering covered by such registration
statement has been withdrawn or until thirty (30) days after such offering is consummated. The demand for registration may be
made at any time during a period of five (5) years beginning on the Commencement Date. The Company covenants and agrees to give
written notice of its receipt of any Demand Notice by any Holder(s) to all other registered Holders of the Purchase Warrants and/or
the Registrable Securities within ten (10) days after the date of the receipt of any such Demand Notice.

 

    -3-

     

    

 

4.1.2.
Terms. The Company shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant
to Section 4.1.1, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected
by the Holders to represent them in connection with the sale of the Registrable Securities. The Company agrees to use its reasonable
best efforts to cause the filing required herein to become effective promptly and to qualify or register the Registrable Securities
in such States as are reasonably requested by the Holder(s); provided, however, that in no event shall the Company be required
to register the Registrable Securities in a State in which such registration would cause: (i) the Company to be obligated to register
or license to do business in such State or submit to general service of process in such State, or (ii) the principal shareholders
of the Company to be obligated to escrow their shares of capital stock of the Company. The Company shall cause any registration
statement filed pursuant to the demand right granted under Section 4.1.1 to remain effective for a period of at least twelve (12)
consecutive months after the date that the Holders of the Registrable Securities covered by such registration statement are first
given the opportunity to sell all of such securities. The Holders shall only use the prospectuses provided by the Company to sell
the Warrant ADSs covered by such registration statement, and will immediately cease to use any prospectus furnished by the Company
if the Company advises the Holder that such prospectus may no longer be used due to a material misstatement or omission. Notwithstanding
the provisions of this Section 4.1.2, the Holder shall be entitled to a demand registration under this Section 4.1.2 on only one
(1) occasion and such demand registration right shall terminate on the fifth anniversary of the date of the Underwriting Agreement
(as defined below) in accordance with FINRA Rule 5110(f)(2)(G)(iv).

 

4.2.
“Piggy-Back” Registration.

 

4.2.1.
Grant of Right. In addition to the demand right of registration described in Section 4.1 hereof, the Holder shall have
the right for a period of no more than seven (7) years from the Commencement Date in accordance with FINRA Rule 5110(f)(2)(G)(v),
to include the Registrable Securities as part of any other registration of securities filed by the Company (other than in connection
with a transaction contemplated by Rule 145(a) promulgated under the Act or pursuant to Form S-8 or any equivalent form); provided,
however, that if, solely in connection with any primary underwritten public offering for the account of the Company, the managing
underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the number of ADSs which may be included in
the Registration Statement because, in such underwriter(s)’ judgment, marketing or other factors dictate such limitation is necessary
to facilitate public distribution, then the Company shall be obligated to include in such Registration Statement only such limited
portion of the Registrable Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall
reasonably permit. Any exclusion of Registrable Securities shall be made pro rata among the Holders seeking to include Registrable
Securities in proportion to the number of Registrable Securities sought to be included by such Holders; provided, however, that
the Company shall not exclude any Registrable Securities unless the Company has first excluded all outstanding securities, the
holders of which are not entitled to inclusion of such securities in such Registration Statement or are not entitled to pro rata
inclusion with the Registrable Securities.

 

4.2.2
Terms. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section
4.2.1 hereof, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by
the Holders to represent them in connection with the sale of the Registrable Securities. In the event of such a proposed registration,
the Company shall furnish the then Holders of outstanding Registrable Securities with not less than ten (10) days written notice
prior to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for
each registration statement filed by the Company during the two (2) year period following the Commencement Date until such time
as all of the Registrable Securities have been registered for resale under the Act or sold by the Holder. The holders of the Registrable
Securities shall exercise the “piggy-back” rights provided for herein by giving written notice within ten (10) days
of the receipt of the Company’s notice of its intention to file a registration statement. Except as otherwise provided in this
Purchase Warrant, there shall be no limit on the number of times the Holder may request registration under this Section 4.2.2;
provided, however, that such “piggy-back” registration rights shall terminate on the seventh (7th) anniversary
of the Commencement Date in accordance with FINRA Rule 5110(f)(2)(G)(v).

 

    -4-

     

    

 

4.3
Damages. Should the registration or the effectiveness thereof required by Sections 4.1 and 4.2 hereof be delayed by the
Company or the Company otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or
other relief available to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive)
relief against the threatened breach of such provisions or the continuation of any such breach, without the necessity of proving
actual damages and without the necessity of posting bond or other security.

 

4.4.
Indemnification. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration
statement hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Act or Section
20(a) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), against all loss, claim, damage, expense
or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing or defending
against any claim whatsoever) to which any of them may become subject under the Act, the Exchange Act or otherwise, arising from
such registration statement but only to the same extent and with the same effect as the provisions pursuant to which the Company
has agreed to indemnify the Holder(s) pursuant to the underwriting agreement relating to such registration statement (the “Underwriting
Agreement”). The Holder(s) of the Registrable Securities to be sold pursuant to such registration statement, and their
successors and assigns, shall severally, and not jointly, indemnify the Company, against all loss, claim, damage, expense or liability
(including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing or defending against
any claim whatsoever) to which they may become subject under the Act, the Exchange Act or otherwise, arising from information
furnished by or on behalf of such Holders, or their successors or assigns, in writing, for specific inclusion in such registration
statement to the same extent and with the same effect as the provisions contained in the Underwriting Agreement pursuant to which
the underwriters have agreed to indemnify the Company.

 

4.5.
Exercise of Purchase Warrants. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s)
to exercise their Purchase Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.

 

4.6.
Documents Delivered to Holders. The Company shall deliver promptly to each Holder participating in the offering requesting
the correspondence and memoranda described below and to the managing underwriter, if any, copies of all correspondence between
the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission or its staff
with respect to the registration statement and permit each Holder and underwriter to do such investigation, upon reasonable advance
notice, with respect to information contained in or omitted from the registration statement as it deems reasonably necessary to
comply with applicable securities laws or rules of FINRA. Such investigation shall include access to books, records and properties
and opportunities to discuss the business of the Company with its officers and independent auditors, all to such reasonable extent
and at such reasonable times, during normal business hours, as any such Holder shall reasonably request.

 

4.7.
Underwriting Agreement. If the Company shall enter into an underwriting agreement, pursuant to which Registrable Securities
of a Holder are being registered, such Holders shall not be required to make any representations or warranties to or agreements
with the Company or the underwriters except as they may relate to such Holders, their Warrant ADSs and their intended methods
of distribution.

 

4.8.
Documents to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish
to the Company (i) a completed and executed questionnaire provided by the Company requesting information customarily sought of
selling security holders.

 

5.
New Purchase Warrants to be Issued.

 

5.1.
Partial Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or
assigned in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase
Warrant for cancellation, together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise
Price and/or transfer tax if exercised pursuant to Section 2.1 hereto, the Company shall cause to be delivered to the Holder without
charge a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder
to purchase the number of Warrant ADSs purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.

 

    -5-

     

    

 

5.2.
Lost Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation
of this Purchase Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and
deliver a new Purchase Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such
loss, theft, mutilation or destruction shall constitute a substitute contractual obligation on the part of the Company.

 

6.
Adjustments.

 

6.1.
Adjustments to Exercise Price and Number of Warrant ADSs. The Exercise Price and the number of Warrant ADSs underlying
the Purchase Warrant shall be subject to adjustment from time to time as hereinafter set forth:

 

6.1.1.
Share Dividends; Split Ups. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of
outstanding Shares or ADSs is increased by a share dividend payable in Shares or ADSs or by a split up of Shares or ADSs or other
similar event, then, on the effective day thereof, the number of Warrant ADSs purchasable hereunder shall be increased in proportion
to such increase in outstanding Shares or ADSs, and the Exercise Price shall be proportionately decreased.

 

6.1.2.
Aggregation of Shares. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding
Shares or ADSs is decreased by a consolidation, combination or reclassification of Shares or ADSs or other similar event, then,
on the effective date thereof, the number of Warrant ADSs purchasable hereunder shall be decreased in proportion to such decrease
in outstanding Shares or ADSs, and the Exercise Price shall be proportionately increased.

 

6.1.3.
Replacement of Securities Upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding
Shares or ADSs other than a change covered by Section 6.1.1 or Section 6.1.2 hereof or that solely affects the par value of such
Shares or ADSs, or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into another
corporation (other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation
and that does not result in any reclassification or reorganization of the outstanding Shares or ADSs), or in the case of any sale
or conveyance to another corporation or entity of the property of the Company as an entirety or substantially as an entirety in
connection with which the Company is dissolved, this Purchase Warrant shall, immediately after such reorganization, reclassification,
consolidation, merger, sale or similar transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as
the case may be) the number of Warrant ADSs then exercisable under this Purchase Warrant, be exercisable for the kind and number
of shares of stock or other securities or assets of the Company or of the successor person resulting from such transaction to
which the Holder would have been entitled upon such reorganization, reclassification, consolidation, merger, sale or similar transaction
if the Holder had exercised this Purchase Warrant in full immediately prior to the time of such reorganization, reclassification,
consolidation, merger, sale or similar transaction and acquired the applicable number of Shares then issuable hereunder as a result
of such exercise (without taking into account any limitations or restrictions on the exercisability of this Purchase Warrant);
and, in such case, appropriate adjustment shall be made with respect to the Holder’s rights under this Purchase Warrant to insure
that the provisions of this Section 6.1.3 hereof shall thereafter be applicable, as nearly as possible, to this Purchase Warrant
in relation to any shares of stock, securities or assets thereafter acquirable upon exercise of this Purchase Warrant (including,
in the case of any consolidation, merger, sale or similar transaction in which the successor or purchasing person is other than
the Company, an immediate adjustment in the Exercise Price to the value per Share reflected by the terms of such consolidation,
merger, sale or similar transaction, and a corresponding immediate adjustment to the number of Warrant ADSs acquirable upon exercise
of this Purchase Warrant without regard to any limitations or restrictions on exercise, if the value so reflected is less than
the Exercise Price in effect immediately prior to such consolidation, merger, sale or similar transaction). The provisions of
this Section 6.1.3 shall similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales or similar
transactions. The Company shall not effect any such reorganization, reclassification, consolidation, merger, sale or similar transaction
unless, prior to the consummation thereof, the successor person (if other than the Company) resulting from such reorganization,
reclassification, consolidation, merger, sale or similar transaction, shall assume, by written instrument substantially similar
in form and substance to this Purchase Warrant and satisfactory to the Holder, the obligation to deliver to the Holder such shares
of stock, securities or assets which, in accordance with the foregoing provisions, such Holder shall be entitled to receive upon
exercise of this Purchase Warrant.

 

    -6-

     

    

 

6.1.4.
Changes in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to
this Section 6.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Warrant
ADSs as are stated in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance
of new Purchase Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring
after the Commencement Date or the computation thereof.

 

6.2.
Substitute Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation
of the Company with or into, another corporation (other than a consolidation or share reconstruction or amalgamation which does
not result in any reclassification or change of the outstanding Shares or ADSs), the corporation formed by such consolidation
or share reconstruction or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that
the holder of each Purchase Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration
of such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the kind and amount of shares and other securities
and property receivable upon such consolidation or share reconstruction or amalgamation, by a holder of the number of ADSs of
the Company for which such Purchase Warrant might have been exercised immediately prior to such consolidation, share reconstruction
or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to
the adjustments provided for in this Section 6. The above provision of this Section shall similarly apply to successive consolidations
or share reconstructions or amalgamations.

 

6.3.
Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of
Shares upon the exercise of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional
interests, it being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction up or
down, as the case may be, to the nearest whole number of Shares or other securities, properties or rights.3

 

7.
Reservation and Listing. The Company shall at all times reserve and keep available out of its authorized Shares, solely
for the purpose of issuance upon exercise of the Purchase Warrants, such number of Shares or other securities, properties or rights
to provide for he issuance of the Warrant ADSs upon the exercise of any purchase rights under this Purchase Warrant. The Company
covenants and agrees that, upon exercise of the Purchase Warrants and payment of the Exercise Price therefor, in accordance with
the terms hereby, all Warrant ADSs and other securities issuable upon such exercise shall be duly and validly issued, fully paid
and non-assessable and not subject to preemptive rights of any shareholder. As long as the Purchase Warrants shall be outstanding,
the Company shall use its commercially reasonable efforts to cause all Warrant ADSs issuable upon exercise of the Purchase Warrants
to be listed (subject to official notice of issuance) on all national securities exchanges (or, if applicable, quoted on the OTC
Bulletin Board or any successor trading market) on which the Company’s ADSs may then be listed and/or quoted.

 

8.
Certain Notice Requirements.

 

8.1.
Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or
consent or to receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever
as a shareholder of the Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise,
any of the events described in Section 8.2 shall occur, then, in one or more of said events, the Company shall give written notice
of such event at least ten (10) days prior to the date fixed as a record date or the date of closing the transfer books for the
determination of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription
rights, or entitled to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record
date or the date of the closing of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver
to each Holder a copy of each notice given to the other shareholders of the Company at the same time and in the same manner that
such notice is given to the shareholders.

 

 

		3	NTD is rounding up is permissible pursuant to Cayman laws.

 

    -7-

     

    

  

8.2.
Events Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more
of the following events: (i) if the Company shall take a record of the holders of its Shares or ADSs for the purpose of entitling
them to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise
than out of retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company,
(ii) the Company shall offer to all the holders of its Shares or ADSs any additional shares of capital stock of the Company or
securities convertible into or exchangeable for shares of capital stock of the Company, or any option, right or warrant to subscribe
therefor, or (iii) a dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or share
reconstruction or amalgamation) or a sale of all or substantially all of its property, assets and business shall be proposed.

 

8.3.
Notice of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price
pursuant to Section 6 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price
Notice shall describe the event causing the change and the method of calculating same and shall be certified as being true and
accurate by the Company’s Chief Financial Officer.

 

8.4.
Transmittal of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in
writing and shall be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service:
(i) if to the registered Holder of the Purchase Warrant, to the address of such Holder as shown on the books of the Company, or
(ii) if to the Company, to following address or to such other address as the Company may designate by notice to the Holders:

 

If
to the Holder:

 

The
Benchmark Company LLC

150
East 58th Street 17th Floor

New
York, NY 10155

Attn:
[●]

 

If
to the Company:

 

[●]

Attn:
[●]

 

9.
Miscellaneous.

 

9.1.
Amendments. The Company and Benchmark may from time to time supplement or amend this Purchase Warrant without the approval
of any of the Holders in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective
or inconsistent with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder
that the Company and Benchmark may deem necessary or desirable and that the Company and Benchmark deem shall not adversely affect
the interest of the Holders. All other modifications or amendments shall require the written consent of and be signed by the party
against whom enforcement of the modification or amendment is sought.

 

9.2.
Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way
limit or affect the meaning or interpretation of any of the terms or provisions of this Purchase Warrant.

 

9.3.
Entire Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or
in connection with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter
hereof, and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter
hereof.

 

    -8-

     

    

 

9.4.
Binding Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the
Company and their permitted assignees, respective successors, legal representative and assigns, and no other person shall have
or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant
or any provisions herein contained.

 

9.5.
Governing Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed and
enforced in accordance with the laws of the State of New York, without giving effect to conflict of laws principles thereof. Each
of the Company and the Holder hereby agrees that any action, proceeding or claim against it arising out of, or relating in any
way to this Purchase Warrant shall be brought and enforced in the New York Supreme Court, County of New York, or in the United
States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive. Each of the Company and the Holder hereby waives any objection to such exclusive jurisdiction and that such
courts represent an inconvenient forum. Any process or summons to be served upon the Company or the Holder may be served by transmitting
a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set
forth in Section 8 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company and the
Holder in any action, proceeding or claim. The Company and the Holder agree that the prevailing party(ies) in any such action
shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees and expenses relating to such action
or proceeding and/or incurred in connection with the preparation therefor. The Company (on its behalf and, to the extent permitted
by applicable law, on behalf of its shareholders and affiliates) hereby irrevocably waives, to the fullest extent permitted by
applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby.

 

9.6.
Waiver, etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant
shall not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase
Warrant or any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this
Purchase Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant
shall be effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement
of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to
be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.

 

9.7.
Exchange Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that,
at any time prior to the complete exercise of this Purchase Warrant by Holder, if the Company and Benchmark enter into an agreement
(“Exchange Agreement”) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged
for securities or cash or a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

[Signature
Page Follows]

 

IN
WITNESS WHEREOF, the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the [●]
day of [●], 20[●].

 

WIMI
HOLOGRAM CLOUD, INC.

 

	By:	 	 
	 	Name:	 
	 	Title:	 

 

    -9-

     

    

 

[Form
to be used to exercise Purchase Warrant]

Date:

 

The
undersigned hereby elects irrevocably to exercise the Purchase Warrant for [●] Warrant ADSs, of WiMi Hologram Cloud, Inc.,
a corporation governed by the laws of the Cayman Islands (the “Company”), and hereby makes payment of $ (at the
rate of $[●] per Warrant ADS) in payment of the Exercise Price pursuant thereto. Please issue the Warrant ADSs as to which
this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a new Purchase Warrant
representing the number of Warrant ADSs for which this Purchase Warrant has not been exercised.

 

Or

 

The
undersigned hereby elects irrevocably to convert its right to purchase [●] Warrant ADSs of the Company under the Purchase
Warrant for [●] Warrant ADSs, as determined in accordance with the following formula:

	 	 	 	 	 	 	 	 
	X 	 	=	 	Y(A-B)
    	 	 	 
	 	 	A	 	 	 
	 	 	 	 	 	 	 	 	 	 	 
	Where,	 	 	 	 	 	 	 	 	 	 
	 	 	 	 
	 	 	X	 	=	 	The number
    of Warrant ADSs to be issued to Holder;	 
	 	 	Y	 	=	 	The number
    of Warrant ADSs for which the Purchase Warrant is being exercised;	 
	 	 	A	 	=	 	The fair
    market value of one Warrant ADS which is equal to $[●]; and	 
	 	 	B	 	=	 	The Exercise
    Price which is equal to $[●] per share	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

The
undersigned agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement
with respect to the calculation shall be resolved by the Company in its sole discretion.

 

Please
issue the Warrant ADSs as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if
applicable, a new Purchase Warrant representing the number of Warrant ADSs for which this Purchase Warrant has not been converted.

 

Signature:
_______________________________

 

Signature
Guaranteed: _______________________________

 

INSTRUCTIONS
FOR REGISTRATION OF SECURITIES

	 	 	 
	Name:	 	 
	 	(Print
    in Block Letters)	 
	 	 	 
	Address:	 	 
	 	 	 
	 	 	 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or
enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by
a firm having membership on a registered national securities exchange.

 

    -10-

     

    

  

[Form
to be used to assign Purchase Warrant]

 

ASSIGNMENT

 

(To
be executed by the registered Holder to effect a transfer of the within Purchase Warrant):

 

FOR
VALUE RECEIVED, [●] does hereby sell, assign and transfer unto the right to purchase Warrant ADSs, of WiMi Hologram Cloud,
Inc., a corporation governed by the laws of the Cayman Islands (the “Company”), evidenced by the Purchase Warrant
and does hereby authorize the Company to transfer such right on the books of the Company.

 

Dated:
_____________________________

 

Signature
: _____________________________

 

Signature
Guaranteed : _____________________________

 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the within Purchase Warrant without alteration
or enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or
by a firm having membership on a registered national securities exchange.

 

 

-11-Exhibit
10.21

 

INDEMNIFICATION
AGREEMENT

 

THIS
INDEMNIFICATION AGREEMENT (this “Agreement”) is made as of, 2020 by and between WiMi Hologram Cloud Inc.,
an exempted company with limited liability incorporated and existing under the laws of the Cayman Islands (the “Company”),
and                             ([Passport/ID] Number                         ) (the “Indemnitee”).

 

WHEREAS,
the Indemnitee has agreed to serve as a director or executive officer of the Company and in such capacity will render valuable
services to the Company; and

 

WHEREAS,
in order to induce and encourage highly experienced and capable persons such as the Indemnitee to render valuable services to
the Company, the board of directors of the Company (the “Board of Directors”) has determined that this Agreement
is not only reasonable and prudent, but necessary to promote and ensure the best interests of the Company and its shareholders;

 

NOW,
THEREFORE, in consideration of the premises and mutual agreements hereinafter set forth, and other good and valuable consideration,
including, without limitation, the service of the Indemnitee, the receipt of which hereby is acknowledged, and in order to induce
the Indemnitee to render valuable services the Company, the Company and the Indemnitee hereby agree as follows:

 

1. Definitions.
As used in this Agreement:

 

(a)
 Change in Control” shall mean a change in control of the Company
of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or in response to
any similar item on any similar or successor schedule or form) promulgated under the United States Securities Exchange Act of
1934, as amended, and the rules and regulations promulgated thereunder (collectively, the “Act”), whether or
not the Company is then subject to such reporting requirement; provided, however, that, without limitation, such a Change in Control
shall be deemed to have occurred (irrespective of the applicability of the initial clause of this definition) if (i) any “person”
(as such term is used in Sections 13(d) and 14(d) of the Act, but excluding any trustee or other fiduciary holding securities
pursuant to an employee benefit or welfare plan or employee share plan of the Company or any subsidiary or affiliate of the Company,
or any entity organized, appointed, established or holding securities of the Company with voting power for or pursuant to the
terms of any such plan) becomes the “beneficial owner” (as defined in Rule 13d-3 under the Act), directly or indirectly,
of securities of the Company representing 30% or more of the combined voting power of the Company’s then outstanding securities
without the prior approval of at least two-thirds of the Continuing Directors (as defined below) in office immediately prior to
such person’s attaining such interest; (ii) the Company is a party to a merger, consolidation, scheme of arrangement, sale
of assets or other reorganization, or a proxy contest, as a consequence of which Continuing Directors in office immediately prior
to such transaction or event constitute less than a majority of the Board of Directors of the Company (or any successor entity)
thereafter; or (iii) during any period of two (2) consecutive years, Continuing Directors cease for any reason to constitute at
least a majority of the Board of Directors of the Company.

 

(b)
“Continuing Director” shall mean an individual (i) who served on the Board of Directors of the Company
at the effective date of the Company’s registration statement on Form F-1 relating to the Company’s initial public
offering; or (ii) whose election or nomination for election by the Company’s shareholders was approved in accordance with
the Articles of the Company.

 

(c) “Disinterested
Director” with respect to any request by the Indemnitee for indemnification or advancement of expenses hereunder shall
mean a director of the Company who neither is nor was a party to the Proceeding (as defined below) in respect of which indemnification
or advancement is being sought by the Indemnitee.

 

(d) The
term “Expenses” shall mean, without limitation, expenses of Proceedings, including attorneys’ fees, disbursements
and retainers, accounting and witness fees, expenses related to preparation for service as a witness and to service as a witness,
travel and deposition costs, expenses of investigations, judicial or administrative proceedings and appeals, amounts paid in settlement
of a Proceeding by or on behalf of the Indemnitee, costs of attachment or similar bonds, any expenses of attempting to establish
or establishing a right to indemnification or advancement of expenses, under this Agreement, the Company’s Memorandum of
Association and Articles of Association as currently in effect (the “Articles”), applicable law or otherwise,
and reasonable compensation for time spent by the Indemnitee in connection with the investigation, defense or appeal of a Proceeding
or action for indemnification for which the Indemnitee is not otherwise compensated by the Company or any third party. The term
“Expenses” shall not include the amount of judgments, fines, interest or penalties, which are actually levied against
or sustained by the Indemnitee to the extent sustained after final adjudication.

 

(e) The
term “Independent Legal Counsel” shall mean any firm of attorneys reasonably selected by the Board of
Directors of the Company, so long as such firm has not represented the Company, the Company’s subsidiaries or affiliates,
the Indemnitee, any entity controlled by the Indemnitee, or any party adverse to the Company, within the preceding five (5) years.
Notwithstanding the foregoing, the term “Independent Legal Counsel” shall not include any person who, under applicable
standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or the
Indemnitee in an action to determine the Indemnitee’s right to indemnification or advancement of expenses under this Agreement,
the Company’s Articles, applicable law or otherwise.

 

     

     

    

 

(f) The
term “Proceeding” shall mean any threatened, pending or completed action, suit, arbitration, alternate dispute
resolution mechanism, or other proceeding (including, without limitation, an appeal therefrom), formal or informal, whether brought
in the name of the Company or otherwise, whether of a civil, criminal, administrative or investigative nature, and whether by,
in or involving a court or an administrative, other governmental or private entity or body (including, without limitation, an
investigation by the Company or its Board of Directors), by reason of (i) the fact that the Indemnitee is or was a director or
officer of the Company, or is or was serving at the request of the Company as an agent of another enterprise, whether or not the
Indemnitee is serving in such capacity at the time any liability or expense is incurred for which indemnification or reimbursement
is to be provided under this Agreement, (ii) any actual or alleged act or omission or neglect or breach of duty, including, without
limitation, any actual or alleged error or misstatement or misleading statement, which the Indemnitee commits or suffers while
acting in any such capacity, or (iii) the Indemnitee attempting to establish or establishing a right to indemnification or advancement
of expenses pursuant to this Agreement, the Company’s Articles, applicable law or otherwise.

 

(g)
The phrase “serving at the request of the Company as an agent of another enterprise” or any similar
terminology shall mean, unless the context otherwise requires, serving at the request of the Company as a director, officer,
employee or agent of another corporation, partnership, joint venture, limited liability company, trust, employee benefit or
welfare plan or other enterprise, foreign or domestic. The phrase “serving at the request of the Company” shall
include, without limitation, any service as a director/an executive officer of the Company which imposes duties on, or
involves services by, such director/executive officer with respect to the Company or any of the Company’s subsidiaries,
affiliates, employee benefit or welfare plans, such plan’s participants or beneficiaries or any other enterprise,
foreign or domestic. In the event that the Indemnitee shall be a director, officer, employee or agent of another corporation,
partnership, joint venture, limited liability company, trust, employee benefit or welfare plan or other enterprise, foreign
or domestic, 50% or more of the ordinary shares, combined voting power or total equity interest of which is owned by the
Company or any subsidiary or affiliate thereof, then it shall be presumed conclusively that the Indemnitee is so acting at
the request of the Company.

 

2. Services
by the Indemnitee. The Indemnitee agrees to serve as a director or officer of the Company under the terms of the Indemnitee’s
agreement with the Company for so long as the Indemnitee is duly elected or appointed or until such time as the Indemnitee tenders
a resignation in writing or is removed from the Indemnitee’s position; provided, however, that the Indemnitee may at any
time and for any reason resign from such position (subject to any other contractual obligation or other obligation imposed by
operation of law).

 

3. Proceedings
by or in the Right of the Company. The Company shall indemnify the Indemnitee if the Indemnitee is a party to or threatened
to be made a party to or is otherwise involved in any Proceeding by or in the right of the Company to procure a judgment in its
favor by reason of the fact that the Indemnitee is or was a director or officer of the Company, or is or was serving at the request
of the Company as an agent of another enterprise, against all Expenses, judgments, fines, interest or penalties, which are actually
and reasonably incurred by the Indemnitee in connection with the defense or settlement of such a Proceeding, if the Indemnitee
acted in good faith and in a manner the Indemnitee reasonably believed to be in, or not opposed to, the best interests of the
Company; except that no indemnification under this section shall be made in respect of any claim, issue or matter as to
which such person shall have been adjudicated by final judgment by a court of competent jurisdiction to be liable to the Company
for willful misconduct in the performance of his/her duty to the Company, unless and only to the extent that the court in which
such Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the
circumstances of the case, such person is fairly and reasonably entitled to indemnity for such amounts which such other court
shall deem proper.

 

4.
Proceeding Other Than a Proceeding by or in the Right of the Company. The Company shall indemnify the
Indemnitee if the Indemnitee is a party to or threatened to be made a party to or is otherwise involved in any Proceeding (other
than a Proceeding by or in the right of the Company) by reason of the fact that the Indemnitee is or was a director or officer
of the Company, or is or was serving at the request of the Company as an agent of another enterprise, against all Expenses, judgments,
fines, interest or penalties, which are actually and reasonably incurred by the Indemnitee in connection with such a Proceeding,
to the fullest extent permitted by applicable law; provided, however, that any settlement of a Proceeding must be approved in
advance in writing by the Company (which approval shall not be unreasonably withheld).

 

5. Indemnification
for Costs, Charges and Expenses of Witness or Successful Party. Notwithstanding any other provision of this Agreement (except
as set forth in subparagraph 9(a) hereof), and without a requirement for determination as required by Paragraph 8 hereof, to the
extent that the Indemnitee (a) has prepared to serve or has served as a witness in any Proceeding in any way relating to (i) the
Company or any of the Company’s subsidiaries, affiliates, employee benefit or welfare plans or such plan’s participants
or beneficiaries or (ii) anything done or not done by the Indemnitee as a director or officer of the Company or in connection
with serving at the request of the Company as an agent of another enterprise, or (b) has been successful in defense of any Proceeding
or in defense of any claim, issue or matter therein, on the merits or otherwise, including the dismissal of a Proceeding without
prejudice or the settlement of a Proceeding without an admission of liability, the Indemnitee shall be indemnified against all
Expenses actually and reasonably incurred by the Indemnitee in connection therewith to the fullest extent permitted by applicable
law.

 

    2

     

    

 

6. Partial
Indemnification. If the Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for
a portion of the Expenses, judgments, fines, interest or penalties, which are actually and reasonably incurred by the Indemnitee
in the investigation, defense, appeal or settlement of any Proceeding, but not, however, for the total amount of the Indemnitee’s
Expenses, judgments, fines, interest or penalties, then the Company shall nevertheless indemnify the Indemnitee for the portion
of such Expenses, judgments, fines, interest or penalties to which the Indemnitee is entitled.

 

7. Advancement
of Expenses. The Expenses incurred by the Indemnitee in any Proceeding shall be paid promptly by the Company in advance of
the final disposition of the Proceeding at the written request of the Indemnitee, to the fullest extent permitted by applicable
law; provided, however, that the Indemnitee shall set forth in such request reasonable evidence that such Expenses have been incurred
by the Indemnitee in connection with such Proceeding, a statement that such Expenses do not relate to any matter described in
subparagraph 9(a) of this Agreement, and an undertaking in writing to repay any advances if it is ultimately determined as provided
in subparagraph 8(b) of this Agreement that the Indemnitee is not entitled to indemnification under this Agreement.

 

8.
Indemnification Procedure; Determination of Right to Indemnification.

 

(a) Promptly
after receipt by the Indemnitee of notice of the commencement of any Proceeding, the Indemnitee shall, if a claim for indemnification
or advancement of Expenses in respect thereof is to be made against the Company under this Agreement, notify the Company of the
commencement thereof in writing. The failure and delay to so notify the Company will not relieve the Company from any liability
which the Company may have to the Indemnitee under this Agreement unless the Company shall have lost significant substantive or
procedural rights with respect to the defense of any Proceeding as a result of such omission to so notify.

 

(b) The
Indemnitee shall be conclusively presumed to have met the relevant standards of conduct, if any, as defined by applicable law,
for indemnification pursuant to this Agreement and shall be absolutely entitled to such indemnification, unless a determination
is made that the Indemnitee has not met such standards by (i) the Board of Directors by a majority vote of a quorum thereof consisting
of Disinterested Directors, (ii) the shareholders of the Company by majority vote of a quorum thereof consisting of shareholders
who are not parties to the Proceeding due to which a claim for indemnification is made under this Agreement, (iii) Independent
Legal Counsel as set forth in a written opinion (it being understood that such Independent Legal Counsel shall make such determination
only if the quorum of Disinterested Directors referred to in clause (i) of this subparagraph 8(b) is not obtainable or if the
Board of Directors of the Company by a majority vote of a quorum thereof consisting of Disinterested Directors so directs), or
(iv) a court of competent jurisdiction; provided, however, that if a Change in Control shall have occurred and the Indemnitee
so requests in writing, such determination shall be made only by a court of competent jurisdiction.

 

(c) If
a claim for indemnification or advancement of Expenses under this Agreement is not paid by the Company within thirty (30) days
after receipt by the Company of written notice thereof, the rights provided by this Agreement shall be enforceable by the Indemnitee
in any court of competent jurisdiction. Such judicial proceeding shall be made de novo. The burden of proving that indemnification
or advances are not appropriate shall be on the Company. Neither the failure of the directors or shareholders of the Company or
Independent Legal Counsel to have made a determination prior to the commencement of such action that indemnification or advancement
of Expenses is proper in the circumstances because the Indemnitee has met the applicable standard of conduct, if any, nor an actual
determination by the directors or shareholders of the Company or Independent Legal Counsel that the Indemnitee has not met the
applicable standard of conduct shall be a defense to an action by the Indemnitee or create a presumption for the purpose of such
an action that the Indemnitee has not met the applicable standard of conduct. The termination of any Proceeding by judgment, order,
settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself (i) create a presumption
that the Indemnitee did not act in good faith and in a manner which he reasonably believed to be in the best interests of the
Company and/or its shareholders, and, with respect to any criminal Proceeding, that the Indemnitee had reasonable cause to believe
that his conduct was unlawful or (ii) otherwise adversely affect the rights of the Indemnitee to indemnification or advancement
of Expenses under this Agreement, except as may be provided herein.

 

(d)
If a court of competent jurisdiction shall determine that the Indemnitee is entitled to any indemnification or advancement
of Expenses hereunder, the Company shall pay all Expenses actually and reasonably incurred by the Indemnitee in connection with
such adjudication (including, but not limited to, any appellate proceedings).

 

    3

     

    

 

(e) With
respect to any Proceeding for which indemnification or advancement of Expenses is requested, the Company will be entitled to participate
therein at its own expense and, except as otherwise provided below, to the extent that it may wish, the Company may assume the
defense thereof, with counsel reasonably satisfactory to the Indemnitee. After notice from the Company to the Indemnitee of its
election to assume the defense of a Proceeding, the Company will not be liable to the Indemnitee under this Agreement for any
Expenses subsequently incurred by the Indemnitee in connection with the defense thereof, other than as provided below. The Company
shall not settle any Proceeding in any manner which would impose any penalty or limitation on the Indemnitee without the Indemnitee’s
written consent. The Indemnitee shall have the right to employ his/her own counsel in any Proceeding, but the fees and expenses
of such counsel incurred after notice from the Company of its assumption of the defense of the Proceeding shall be at the expense
of the Indemnitee, unless (i) the employment of counsel by the Indemnitee has been authorized by the Company, (ii) the Indemnitee
shall have reasonably concluded that there may be a conflict of interest between the Company and the Indemnitee in the conduct
of the defense of a Proceeding, or (iii) the Company shall not in fact have employed counsel to assume the defense of a proceeding,
in each of which cases the fees and expenses of the Indemnitee’s counsel shall be advanced by the Company. The Company shall
not be entitled to assume the defense of any Proceeding brought by or on behalf of the Company or as to which the Indemnitee has
reasonably concluded that there may be a conflict of interest between the Company and the Indemnitee.

 

9. Limitations
on Indemnification. No payments pursuant to this Agreement shall be made by the Company:

 

(a) To
indemnify or advance funds to the Indemnitee for Expenses with respect to (i) Proceedings initiated or brought voluntarily by
the Indemnitee and not by way of defense, except with respect to Proceedings brought to establish or enforce a right to indemnification
under this Agreement or any other statute or law or otherwise as required under applicable law or (ii) Expenses incurred by the
Indemnitee in connection with preparing to serve or serving as a witness in cooperation with any party or entity who or which
has threatened or commenced any action or proceeding against the Company, or any director, officer, employee, trustee, agent,
representative, subsidiary, parent corporation or affiliate of the Company, but such indemnification or advancement of Expenses
in each such case may be provided by the Company if the Board of Directors finds it to be appropriate;

 

(b) To
indemnify the Indemnitee for any Expenses, judgments, fines, interest or penalties sustained in any Proceeding for which payment
is actually made to the Indemnitee under a valid and collectible insurance policy, except in respect of any excess beyond the
amount of payment under such insurance;

 

(c) To
indemnify the Indemnitee for any Expenses, judgments, fines, interest or penalties sustained in any Proceeding for an
accounting of profits made from the purchase or sale by the Indemnitee of securities of the Company pursuant to the
provisions of Section 16(b) of the Act or similar provisions of any foreign or United States federal, state or local statute
or regulation;

 

(d) To
indemnify the Indemnitee for any Expenses, judgments, fines, interest or penalties for which the Indemnitee is indemnified by
the Company otherwise than pursuant to this Agreement;

 

(e) To
indemnify the Indemnitee for any Expenses (including without limitation any Expenses relating to a Proceeding attempting to enforce
this Agreement), judgments, fines, interest or penalties on account of the Indemnitee’s conduct if such conduct shall be
finally adjudged to have been knowingly fraudulent or deliberately dishonest or to have constituted willful misconduct, including,
without limitation, breach of the duty of loyalty; or

 

(f) If
a court of competent jurisdiction finally determines that any indemnification hereunder is unlawful. In this respect, the Company
and the Indemnitee have been advised that the Securities and Exchange Commission takes the position that indemnification for liabilities
arising under securities laws is against public policy and is, therefore, unenforceable;

 

(g) To
indemnify the Indemnitee in connection with Indemnitee’s personal tax matter; or

 

(h) To
indemnify the Indemnitee with respect to any claim related to any dispute or breach arising under any contract or similar obligation
between the Company or any of its subsidiaries or affiliates and such Indemnitee.

 

10.
Continuation of Indemnification. All agreements and obligations of the Company contained herein shall continue during
the period that the Indemnitee is a director or officer of the Company (or is or was serving at the request of the Company as
an agent of another enterprise, foreign or domestic) and shall continue thereafter so long as the Indemnitee shall be subject
to any possible Proceeding by reason of the fact that the Indemnitee was a director or officer of the Company or serving in any
other capacity referred to in this Paragraph 10.

 

11.
Indemnification Hereunder Not Exclusive. The indemnification provided by this Agreement shall not be deemed to be exclusive
of any other rights to which the Indemnitee may be entitled under the Company’s Articles, any agreement, vote of shareholders
or vote of Disinterested Directors, provisions of applicable law, or otherwise, both as to action or omission in the Indemnitee’s
official capacity and as to action or omission in another capacity on behalf of the Company while holding such office.

 

    4

     

    

 

12.
Successors and Assigns. 

 

(a) This
Agreement shall be binding upon the Indemnitee, and shall inure to the benefit of, the Indemnitee and the Indemnitee’s heirs,
executors, administrators and assigns, whether or not the Indemnitee has ceased to be a director or officer, and the Company and
its successors and assigns. Upon the sale of all or substantially all of the business, assets or share capital of the Company
to, or upon the merger of the Company into or with, any corporation, partnership, joint venture, trust or other person, this Agreement
shall inure to the benefit of and be binding upon both the Indemnitee and such purchaser or successor person. Subject to the foregoing,
this Agreement may not be assigned by either party without the prior written consent of the other party hereto.

 

(b)
If the Indemnitee is deceased and is entitled to indemnification under any provision of this Agreement, the Company shall
indemnify the Indemnitee’s estate and the Indemnitee’s spouse, heirs, executors, administrators and assigns
against, and the Company shall, and does hereby agree to assume, any and all Expenses actually and reasonably incurred by or
for the Indemnitee or the Indemnitee’s estate, in connection with the investigation, defense, appeal or settlement of
any Proceeding. Further, when requested in writing by the spouse of the Indemnitee, and/or the Indemnitee’s heirs,
executors, administrators and assigns, the Company shall provide appropriate evidence of the Company’s agreement set
out herein to indemnify the Indemnitee against and to itself assume such Expenses.

 

13.
Subrogation. In the event of payment under this Agreement, the Company shall be subrogated to the extent of
such payment to all of the rights of recovery of the Indemnitee, who shall execute all documents required and shall do all acts
that may be necessary to secure such rights and to enable the Company effectively to bring suit to enforce such rights.

 

14.
Severability. Each and every paragraph, sentence, term and provision of this Agreement is separate and distinct so
that if any paragraph, sentence, term or provision thereof shall be held to be invalid, unlawful or unenforceable for any reason,
such invalidity, unlawfulness or unenforceability shall not affect the validity, unlawfulness or enforceability of any other paragraph,
sentence, term or provision hereof. To the extent required, any paragraph, sentence, term or provision of this Agreement may be
modified by a court of competent jurisdiction to preserve its validity and to provide the Indemnitee with the broadest possible
indemnification permitted under applicable law. The Company’s inability, pursuant to a court order or decision, to perform
its obligations under this Agreement shall not constitute a breach of this Agreement.

 

15.
Savings Clause. If this Agreement or any paragraph, sentence, term or provision hereof is invalidated on any ground
by any court of competent jurisdiction, the Company shall nevertheless indemnify the Indemnitee as to any Expenses, judgments,
fines, interest or penalties, which are incurred with respect to any Proceeding to the fullest extent permitted by any (a) applicable
paragraph, sentence, term or provision of this Agreement that has not been invalidated or (b) applicable law.

 

16.
Interpretation; Governing Law. This Agreement shall be construed as a whole and in accordance with its fair meaning
and any ambiguities shall not be construed for or against either party. Headings are for convenience only and shall not be used
in construing meaning. This Agreement shall be governed and interpreted in accordance with the laws of the State of New York.

 

17.
Amendments. No amendment, waiver, modification, termination or cancellation of this Agreement shall be effective
unless in writing signed by the party against whom enforcement is sought. The indemnification rights afforded to the Indemnitee
hereby are contract rights and may not be diminished, eliminated or otherwise affected by amendments to the Company’s Articles,
or by other agreements, including directors’ and officers’ liability insurance policies, of the Company.

 

18.
Counterparts. This Agreement may be executed in one or more counterparts, all of which shall be considered one and
the same agreement and shall become effective when one or more counterparts have been signed by each party and delivered to the
other.

 

19.
Notices. Any notice required to be given under this Agreement shall be directed to the Chief Financial Officer of the
Company at No. 6, Xiaozhuang, #101A, Chaoyang District, Beijing 100020, the People’s Republic of China, and to the Indemnitee
at                                            or to such other address as either shall designate to the other in writing.

 

[The
remainder of this page is intentionally left blank.]

 

    5

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Indemnification Agreement as of the date first written above.

 

WiMi
Hologram Cloud Inc.

 

	By:		 
	Name		 
	Title		 

 

INDEMNITEE

 

	By:		 
	Name		 

 

[Signature
Page to Indemnification Agreement of WiMi Hologram Cloud Inc.]

 

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]